OverviewSuggest Edit

Lung Therapeutics is a pharmaceutical company targeting niche, orphan drug indications for lung injury and disease, with an emphasis on fibrosis. The Company is currently developing a drug technology, LTI-03, for the treatment of Idiopathic Pulmonary Fibrosis. Preclinical evidence suggests that LTI-03 sustains survival of damaged lung cells throughout this novel mechanism of action, in addition to slowing and resolving the downstream progress of fibrosis.


... Show more
TypePrivate
Founded2013
HQAustin, US
Websitelungtx.com

Latest Updates

Employees (est.) (Feb 2019)9(-10%)

Key People/Management at Lung Therapeutics

Brian Windsor

Brian Windsor

CEO
Steven Idell

Steven Idell

Founder and Chief Scientific Officer
Andrew Mazar

Andrew Mazar

Founder
John J. Koleng

John J. Koleng

VP CMC - Inhalation Products
Show more

Lung Therapeutics Office Locations

Lung Therapeutics has an office in Austin
Show all (1)
Report incorrect company information

Lung Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2013

Lung Therapeutics total Funding

$17.9 m

Lung Therapeutics latest funding size

$14.30 m

Time since last funding

2 years ago

Lung Therapeutics investors

Lung Therapeutics's latest funding round in June 2017 was reported to be $14.3 m. In total, Lung Therapeutics has raised $17.9 m
Show all financial metrics
Report incorrect company information

Lung Therapeutics Online and Social Media Presence

Embed Graph
Report incorrect company information

Lung Therapeutics Blogs

Lung Therapeutics, Inc. Announces New Chief Financial Officer and Board Member

AUSTIN, TX, February 4, 2019 – Lung Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for orphan, pulmonary indications, announced today the hiring of Charles T. Garner as Chief Financial Officer and the appointment of R.A. Session, II, to the company’s Boa…

Lung Therapeutics Company Life and Culture

Report incorrect company information

Lung Therapeutics Frequently Asked Questions

  • When was Lung Therapeutics founded?

    Lung Therapeutics was founded in 2013.

  • Who are Lung Therapeutics key executives?

    Lung Therapeutics's key executives are Brian Windsor, Steven Idell and Andrew Mazar.

  • How many employees does Lung Therapeutics have?

    Lung Therapeutics has 9 employees.

  • Who are Lung Therapeutics competitors?

    Competitors of Lung Therapeutics include Opiant Pharmaceuticals, IntelGenx and Generex Biotechnology.

  • Where are Lung Therapeutics offices?

    Lung Therapeutics has an office in Austin.

  • How many offices does Lung Therapeutics have?

    Lung Therapeutics has 1 office.